ADVIL
NDC 0573-0154, ibuprofen, tablet, coated, from Haleon US Holdings LLC.
- Product NDC
- 0573-0154
- Status
- Listed
- Labeler
- Haleon US Holdings LLC
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA018989
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0573-0154 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IBUPROFEN200 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0573-0154-16 | 00573015416 | 3 POUCH in 1 CARTON (0573-0154-16) / 2 TABLET, COATED in 1 POUCH |
| 0573-0154-17 | 00573015417 | 3000 POUCH in 1 CASE (0573-0154-17) / 2 TABLET, COATED in 1 POUCH |
| 0573-0154-21 | 00573015421 | 200 TABLET, COATED in 1 BOTTLE (0573-0154-21) |
| 0573-0154-35 | 00573015435 | 1 BOTTLE in 1 CARTON (0573-0154-35) / 150 TABLET, COATED in 1 BOTTLE |
| 0573-0154-59 | 00573015459 | 1 BOTTLE in 1 CARTON (0573-0154-59) / 200 TABLET, COATED in 1 BOTTLE |
| 0573-0154-60 | 00573015460 | 360 TABLET, COATED in 1 BOTTLE (0573-0154-60) |
| 0573-0154-75 | 00573015475 | 1 BOTTLE in 1 CARTON (0573-0154-75) / 200 TABLET, COATED in 1 BOTTLE |
| 0573-0154-84 | 00573015484 | 1 BOTTLE in 1 CARTON (0573-0154-84) / 225 TABLET, COATED in 1 BOTTLE |
| 0573-0154-89 | 00573015489 | 50 POUCH in 1 CASE (0573-0154-89) / 2 TABLET, COATED in 1 POUCH |
| 0573-0154-98 | 00573015498 | 300 TABLET, COATED in 1 BOTTLE (0573-0154-98) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0573-0154 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0573-0154 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0573-0154. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.